Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 703685, 8 pages
Clinical Study

Incidence and Predictors of New-Onset Silent Atrial Fibrillation after Coronary Artery Bypass Graft Surgery

1University Hospital, Department of Cardiology, 21000 Dijon, France
2INSERM, U866, LPPCM, 21000 Dijon, France
3University Hospital, Department of Cardiothoracic Surgery, 21000 Dijon, France
4CNRS, UMR 5158, Le2I, 21000 Dijon, France

Received 7 April 2015; Revised 5 July 2015; Accepted 12 July 2015

Academic Editor: Christof Kolb

Copyright © 2015 Charles Guenancia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Aims. We investigated the incidence, risk factors, and prognostic impact of silent atrial fibrillation (AF) after coronary artery bypass graft (CABG) surgery. Methods. This observational study prospectively included 100 patients referred for CABG surgery. Holter ECG monitoring was used to record every arrhythmic event for 7 days. AF was defined as at least one episode >30 s. Episodes recorded on Holter ECG monitoring but not clinically identified were classified as silent AF. Results. Among 34 patients who developed new-onset AF, 13 had silent AF. Compared with patients with maintained sinus rhythm (SR), silent AF patients had a significantly higher logistic EuroSCORE (2.9 (1.5–5.2) versus 2.3 (1.4–3.7), ) and were more likely to have previous sleep apnea (31% versus 8%, ) and left atrial diameter >45 mm (36% versus 5%, ). At one-year follow-up, 30% of silent AF patients had developed symptomatic AF versus 7% in the SR group () and 11% in the clinical AF group (). Conclusion. After CABG surgery, silent AF is common and may be associated with a higher incidence of recurrences at one-year follow-up than clinical AF. Improved screening for silent AF may help to reduce thromboembolic events in this high-risk population.